// App-Quantinova.ai

: The Expression of SREBF1 Inducing By Dexamethasone Promotes Bone Marrow Mesenchymal Stromal Cells Differentiate to Adipocytes to Attract and Protect the Residual T-Cell Acute Lymphoblastic Leukemia Cells

Researchers

Presenter

  • Ruinan Jia

Principal Investigators

  • Min Ji

  • Tao Sun

  • Jingjing Ye

  • Chunyan Ji

Medical Centers

  • Qilu Hospital of Shandong University, Jinan, China

  • Department of Hematology, Qilu Hospital of Shandong University, Jinan, China

  • Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

Locations

  • China

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • C-X-C Motif Chemokine Ligand 13

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A